MARKET

AGE

AGE

AgeX Therapeutics
AMEX

Real-time Quotes | Nasdaq Last Sale

2.380
-0.010
-0.42%
After Hours: 2.380 0 0.00% 16:00 09/19 EDT
OPEN
2.380
PREV CLOSE
2.390
HIGH
2.470
LOW
2.380
VOLUME
31.94K
TURNOVER
--
52 WEEK HIGH
5.95
52 WEEK LOW
1.130
MARKET CAP
89.56M
P/E (TTM)
-7.4352
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AGE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

AGE News

  • Industry Leaders Aubrey De Grey And Frank Jaksch Join Yuva Biosciences Advisory Board
  • PR Newswire.09/10 13:00
  • AgeX Therapeutics Presents at the Rodman & Renshaw Global Investment Conference
  • Business Wire.09/09 12:00
  • AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine
  • Business Wire.09/04 13:00
  • 75 Biggest Movers From Yesterday
  • Benzinga.08/16 09:16

More

Industry

Biotechnology & Medical Research
+0.06%
Pharmaceuticals & Medical Research
+0.42%

Hot Stocks

Name
Price
%Change

About AGE

AgeX Therapeutics Inc. is a biotechnology company. The Company is focused on the development and commercialization of therapeutics targeting human aging. Its induced Tissue Regeneration (iTR) technology is based telomerase-mediated cellular immortality and regenerative biology. Its pipeline includes two cell-based, two drug-based therapeutic products, online database products and research products. The Company’s AGEX-BAT1 is its cell therapy product candidate that is being developed for the treatment of certain age-related metabolic disorders, such as Type II (adult-onset) diabetes. AGEX-VASC1 is its cell-based therapy that is designed to restore vascular support in aged ischemic tissues such as the aging heart. AGEX-iTR1547 is its drug-based formulation developed to restore regenerative potential in an array of aged tissues afflicted with degenerative disease using its proprietary iTR technology. Renelon is its iTR product candidate designed to promote scar less tissue repair.
More

Webull offers AgeX Therapeutics Inc (AGE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.